Reply to: “Re-evaluating pyoderma gangrenosum patients for Behçet disease before initiating any invasive procedures is essential”

To the Editor: We would like to thank Dr Aksoy1 for drawing attention to the unique challenges facing patients with Behçet syndrome in the perioperative setting. Her comments serve as an important reminder for physicians who are translating research into the clinical setting: we must consider the representativeness of the study sample when we generalize results to other settings or populations. Our patients' disease was diagnosed by using the Su criteria, and the overall demographics of our cohort are consistent with the known epidemiology of the disease in the United States.